Benitec Biopharma Inc. (BNTC)
BNTC Stock Price Chart
Explore Benitec Biopharma Inc. interactive price chart. Choose custom timeframes to analyze BNTC price movements and trends.
BNTC Company Profile
Discover essential business fundamentals and corporate details for Benitec Biopharma Inc. (BNTC) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
24 Jun 2014
Employees
16.00
Website
https://benitec.comCEO
Jerel A. Banks
Description
Benitec Biopharma Inc. is an emerging biotechnology firm dedicated to advancing groundbreaking genetic medicines. The company specializes in DNA-directed RNA interference (RNAi) based treatments, which it develops to address severe and enduring human conditions. Its pipeline features BB-301, an adeno-associated virus (AAV) gene therapy aimed at treating oculopharyngeal muscular dystrophy, and BB-103, designed to combat chronic hepatitis B virus infection. Established in 1995, Benitec Biopharma's main operations are situated in Hayward, California.
BNTC Financial Timeline
Browse a chronological timeline of Benitec Biopharma Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 30 Sept 2026
EPS estimate is -$0.28, while revenue estimate is $13.70m.
Upcoming earnings on 28 Sept 2026
EPS estimate is -$0.25.
Earnings released on 14 May 2026
EPS came in at -$0.24 surpassing the estimated -$0.27 by +11.11%.
Earnings released on 12 Feb 2026
EPS came in at -$0.26 falling short of the estimated -$0.23 by -13.04%.
Earnings released on 14 Nov 2025
EPS came in at -$0.22 surpassing the estimated -$0.35 by +37.14%.
Earnings released on 22 Sept 2025
EPS came in at -$0.42 falling short of the estimated -$0.28 by -50.00%, while revenue for the quarter reached $556.00k .
Earnings released on 14 May 2025
EPS came in at -$0.24 surpassing the estimated -$0.36 by +33.33%.
Earnings released on 14 Feb 2025
EPS came in at -$0.36 surpassing the estimated -$1.00 by +64.00%.
Earnings released on 14 Nov 2024
EPS came in at -$0.48 surpassing the estimated -$0.61 by +21.31%.
Earnings released on 26 Sept 2024
EPS came in at -$1.32 falling short of the estimated -$0.49 by -169.39%.
Earnings released on 13 May 2024
EPS came in at -$1.64 falling short of the estimated -$0.78 by -110.26%, while revenue for the quarter reached $3.89k .
Earnings released on 13 Feb 2024
EPS came in at -$2.64 falling short of the estimated -$0.39 by -576.92%.
Earnings released on 13 Nov 2023
EPS came in at -$2.76 falling short of the estimated -$0.51 by -441.18%.
Earnings released on 21 Sept 2023
EPS came in at -$2.83 surpassing the estimated -$3.23 by +12.38%, while revenue for the quarter reached $4.65k .
Stock split effective on 26 Jul 2023
Shares were split 1 : 17 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 15 May 2023
EPS came in at -$2.72 falling short of the estimated -$0.20 by -1.26k%, while revenue for the quarter reached $36.26k .
Earnings released on 13 Feb 2023
EPS came in at -$3.40 falling short of the estimated -$0.11 by -2.99k%, while revenue for the quarter reached $9.57k , missing expectations by -4.32%.
Earnings released on 10 Nov 2022
EPS came in at -$7.99 falling short of the estimated -$2.04 by -291.67%, while revenue for the quarter reached $305.86k , beating expectations by +3.12k%.
Earnings released on 2 Sept 2022
EPS came in at -$10.54 falling short of the estimated -$4.76 by -121.43%, while revenue for the quarter reached $25.00k .
Earnings released on 16 May 2022
EPS came in at -$6.80 surpassing the estimated -$7.48 by +9.09%, while revenue for the quarter reached $36.01k , missing expectations by -31.23%.
Earnings released on 14 Feb 2022
EPS came in at -$10.03 , while revenue for the quarter reached $18.12k .
Earnings released on 15 Nov 2021
EPS came in at -$10.54 .
Earnings released on 20 Sept 2021
EPS came in at -$5.10 , while revenue for the quarter reached $1.50k .
BNTC Stock Performance
Access detailed BNTC performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
